Demyelinating Autoimmune Diseases, CNS Clinical Trial
Official title:
A Registered Cohort Study on Natural Course and Drug Efficacy of Inflammatory Demyelination Disease
This study will provide further insights into the natural course of Inflammatory demyelination disease including clinical features，progression, related antibody spectrum and drug treatment effect
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT05982925 -
Longitudinal Cortical Demyelination in Multiple Sclerosis and Related Disorders
|
||
| Recruiting |
NCT05792176 -
Ukulele Playing to Improve Cognition in People With Multiple Sclerosis: A Feasibility Study
|
N/A | |
| Completed |
NCT04837651 -
Humoral and T-Cell Responses to COVID-19 Vaccination in Multiple Sclerosis Patients Treated With Ocrelizumab Treated With Ocrelizumab or Natalizumab
|
||
| Recruiting |
NCT04786821 -
Acceptability of Exoskeleton Assisted Walking for Persons With Mobility Issues Due to Multiple Sclerosis
|
N/A | |
| Completed |
NCT01056471 -
Autologous Mesenchymal Stem Cells From Adipose Tissue in Patients With Secondary Progressive Multiple Sclerosis
|
Phase 1/Phase 2 | |
| Not yet recruiting |
NCT03297177 -
Autologous Stem/Stromal Cells in Neurological Disorders and Disease
|
N/A | |
| Recruiting |
NCT04762342 -
Power Training in Older Multiple Sclerosis Patients
|
N/A | |
| Completed |
NCT00304291 -
A Pilot Study of Mitoxantrone for the Treatment of Recurrent Neuromyelitis Optica (Devic's Disease)
|
Phase 4 | |
| Recruiting |
NCT04539002 -
Aerobic Exercise for Remyelination in Multiple Sclerosis
|
Phase 1/Phase 2 | |
| Recruiting |
NCT05834855 -
Non-inferiority Study of Rituximab Compared to Ocrelizumab in Relapsing MS
|
Phase 3 | |
| Recruiting |
NCT02862301 -
Epigenetic Evaluation of HAT/HDAC Activity in PBMC From Patients With Clinically Isolated Syndrome
|
N/A |